Celcuity (CELC) Interest Expenses (2017 - 2025)
Celcuity (CELC) reported Interest Expenses of $6.2 million for Q4 2025, up 88.27% on a YoY basis from $3.3 million in Q4 2024, and up 34.19% quarter-over-quarter from $4.6 million in Q3 2025.
Celcuity (CELC) Interest Expenses (2017 - 2025) Analysis & Trends
Celcuity has reported Interest Expenses for 9 years, with the latest figure at $6.2 million in Q4 2025.
- For the quarter ending Q4 2025, Interest Expenses rose 88.27% year-over-year to $6.2 million; the trailing twelve-month figure through Dec 2025 stood at $17.1 million (up 66.81% YoY), and the FY2025 full-year result was $17.1 million, up 66.81% from the prior year.
- Interest Expenses for Q4 2025 stood at $6.2 million, up from $4.6 million in the prior quarter.
- The five-year high for Interest Expenses was $6.2 million in Q4 2025, with the low at $24.0 in Q1 2021.
- Historically, Interest Expenses has averaged $1.8 million across 5 years, with a median of $1.3 million in 2023.
- Annual changes were most pronounced in 2021 — Interest Expenses declined 27.27% — and 2022, when it jumped 1812404.17%.
- Celcuity's Interest Expenses stood at $438067.0 in 2021, then soared by 54.77% to $678003.0 in 2022, then soared by 106.08% to $1.4 million in 2023, then jumped by 134.39% to $3.3 million in 2024, then surged by 88.27% to $6.2 million in 2025.
- The last three Interest Expenses figures came in at $6.2 million (Q4 2025), $4.6 million (Q3 2025), and $3.2 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | -5.50 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | 61,000.00 |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | -332,000.00 |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | -2,753.00 |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | -5.58 Mn |
| 10 | Celcuity | 4.14 Bn | 3.42 Bn | - | 6.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 6.17 Mn |
| Dec 31, 2025 | 6.17 Mn |
| Sep 30, 2025 | 4.60 Mn |
| Sep 30, 2025 | 4.60 Mn |
| Jun 30, 2025 | 3.20 Mn |
| Jun 30, 2025 | 3.20 Mn |
| Mar 31, 2025 | 3.18 Mn |
| Mar 31, 2025 | 3.18 Mn |
| Dec 31, 2024 | 3.28 Mn |
| Dec 31, 2024 | 3.28 Mn |
| Sep 30, 2024 | 3.34 Mn |
| Sep 30, 2024 | 3.34 Mn |
| Jun 30, 2024 | 2.26 Mn |
| Jun 30, 2024 | 2.26 Mn |
| Mar 31, 2024 | 1.40 Mn |
| Mar 31, 2024 | 1.40 Mn |
| Dec 31, 2023 | 1.40 Mn |
| Dec 31, 2023 | 1.40 Mn |
| Sep 30, 2023 | 1.37 Mn |
| Sep 30, 2023 | 1.37 Mn |